Bioventus Stock Performance

BVS
 Stock
  

USD 7.00  0.07  0.99%   

The firm shows a Beta (market volatility) of 1.5341, which signifies a somewhat significant risk relative to the market. Let's try to break down what Bioventus's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bioventus Inc will likely underperform. Even though it is essential to pay attention to Bioventus Inc historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Bioventus Inc Cl exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Bioventus Inc has an expected return of -0.003%. Please be advised to confirm Bioventus Inc semi variance, and the relationship between the treynor ratio and daily balance of power to decide if Bioventus Inc performance from the past will be repeated at some point in the near future.
  
Bioventus Performance
0 of 100
Over the last 90 days Bioventus Inc Cl has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Bioventus Inc is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more

Bioventus Price Channel

Quick Ratio0.86
Fifty Two Week Low6.30
Target High Price30.00
Fifty Two Week High17.53
Target Low Price11.00

Bioventus Inc Relative Risk vs. Return Landscape

If you would invest  745.00  in Bioventus Inc Cl on July 4, 2022 and sell it today you would lose (45.00)  from holding Bioventus Inc Cl or give up 6.04% of portfolio value over 90 days. Bioventus Inc Cl is generating negative expected returns assuming volatility of 4.3026% on return distribution over 90 days investment horizon. In other words, 37% of stocks are less volatile than Bioventus, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Daily Expected Return (%)  
       Risk (%)  
Considering the 90-day investment horizon Bioventus Inc is expected to generate 3.79 times more return on investment than the market. However, the company is 3.79 times more volatile than its market benchmark. It trades about 0.0 of its potential returns per unit of risk. The DOW is currently generating roughly -0.1 per unit of risk.

Bioventus Inc Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioventus Inc's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bioventus Inc Cl, and traders can use it to determine the average amount a Bioventus Inc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -7.0E-4

Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsBVS
Estimated Market Risk
 4.3
  actual daily
 
 37 %
of total potential
 
3737
Expected Return
 0.0
  actual daily
 
 0 %
of total potential
 
00
Risk-Adjusted Return
 0.0
  actual daily
 
 0 %
of total potential
 
00
Based on monthly moving average Bioventus Inc is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bioventus Inc by adding it to a well-diversified portfolio.

About Bioventus Inc Performance

To evaluate Bioventus Inc Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Bioventus Inc generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Bioventus Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Bioventus Inc market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Bioventus's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the bodys natural healing process in the United States and internationally. The company was founded in 2011 and is headquartered in Durham, North Carolina. Bioventus Inc operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1150 people.

Things to note about Bioventus Inc

Checking the ongoing alerts about Bioventus Inc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bioventus Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Bioventus Inc Alerts

Equity Alerts and Improvement Suggestions

Bioventus Inc generated a negative expected return over the last 90 days
Bioventus Inc has high historical volatility and very poor performance
Bioventus Inc has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 466.41 M. Reported Net Loss for the year was (52.6 M) with profit before taxes, overhead, and interest of 302.71 M.
About 65.0% of the company shares are held by institutions such as insurance companies
Continue to Trending Equities. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for analysis

When running Bioventus Inc price analysis, check to measure Bioventus Inc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus Inc is operating at the current time. Most of Bioventus Inc's value examination focuses on studying past and present price action to predict the probability of Bioventus Inc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bioventus Inc's price. Additionally, you may evaluate how the addition of Bioventus Inc to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Is Bioventus Inc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bioventus Inc. If investors know Bioventus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bioventus Inc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bioventus Inc is measured differently than its book value, which is the value of Bioventus that is recorded on the company's balance sheet. Investors also form their own opinion of Bioventus Inc's value that differs from its market value or its book value, called intrinsic value, which is Bioventus Inc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bioventus Inc's market value can be influenced by many factors that don't directly affect Bioventus Inc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bioventus Inc's value and its price as these two are different measures arrived at by different means. Investors typically determine Bioventus Inc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bioventus Inc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.